MedPage Today on MSN
JAK and IL-23 inhibitors for ulcerative colitis: Making decisions about dosage
New data suggest more is better, but choices come with tradeoffs ...
Merck (NYSE:MRK) reported positive Phase 3 results for tulisokibart, an anti-TL1A monoclonal antibody in moderate-to-severe ...
SER-155 recipients achieved immunosuppressive-free clinical response of diarrhea (a primary symptom of irEC) at Day 15 in the ...
Once regarded as a disease affecting people over the age of 50, colorectal cancer is now rising at an alarming rate among ...
A quiet layer of biology is beginning to change how health is understood, and it sits on the surface of nearly every cell in ...
A research team at McMaster University has developed a targeted approach to treating inflammatory bowel disease (IBD) using ...
Brendan Camp, MD, FAAD, is a double board-certified dermatologist and assistant professor of dermatology at Weill Cornell Medical College. Five to 30 minutes of sun exposure on most days without ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results